Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Trimel Pharmaceuticals begins enrollment in phase II Tefina trial

May 18, 2012

New treatments for obesity described by Takeda Pharmaceutical

May 18, 2012

XMetA improves experimental hyperglycemia

May 18, 2012

Repros submits documents to FDA for Androxal SPA

May 17, 2012

Spanish researchers patent new agents for Gaucher's disease

May 17, 2012

Roche reports novel agents for raising HDL cholesterol

May 17, 2012

Blood glucose-lowering agents patented by Daiichi Sankyo

May 16, 2012

Theratechnologies' TH-1173 enters preclinical safety phase

May 14, 2012

Teijin Pharma launches first drip infusion for osteoporosis available in Japan

May 11, 2012

Arena and Eisai expand agreement for lorcaserin

May 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...